Financials
- Market Capitalization 6.38 B
- Employee 258
- Founded 2014
- CEO N/A
- Website www.cogentbio.com
- Headquarter Delaware, United States
- FIGI BBG007DHZQR7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1149 | SRRK Scholar Rock Holding Corporation - Common Stock | 54.74 USD | -3.47% | -1.60% | +22.43% | +82.35% | 6.56 B USD | ||
| 1165 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.00 USD | -2.79% | +11.09% | +28.80% | +64.26% | 6.48 B USD | ||
| 1189 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 311.79 USD | -1.41% | -2.31% | +22.28% | +66.63% | 6.25 B USD | ||
| 1191 | LQDA Liquidia Corporation - Common Stock | 70.78 USD | -9.17% | -11.84% | +0.55% | +213.19% | 6.29 B USD |
Frequently asked questions about Cogent Biosciences, Inc. - Common Stock
What is the Cogent Biosciences, Inc. - Common Stock stock price today?
The current price of Cogent Biosciences, Inc. - Common Stock (COGT) is 37.35. Over the past 24 hours, the stock has changed by -3.91%. Follow the COGT chart for real-time price dynamics.
What is the stock ticker of Cogent Biosciences, Inc. - Common Stock?
Cogent Biosciences, Inc. - Common Stock trades under the ticker COGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cogent Biosciences, Inc. - Common Stock stock going up?
COGT has changed by -5.13% over the last week, +14.71% over the last month, and +138.35% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cogent Biosciences, Inc. - Common Stock net income for the last quarter?
Cogent Biosciences, Inc. - Common Stock reported net income of -97.35 M for the last quarter. The previous quarter showed -102.49 M, which means net income changed by +5.02%.
How many employees does Cogent Biosciences, Inc. - Common Stock have?
As of the latest available data, Cogent Biosciences, Inc. - Common Stock has 258 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cogent Biosciences, Inc. - Common Stock EBITDA?
Cogent Biosciences, Inc. - Common Stock EBITDA is -104.64 M, and its EBITDA margin is 77.51 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cogent Biosciences, Inc. - Common Stock stock?
You can buy Cogent Biosciences, Inc. - Common Stock (COGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cogent Biosciences, Inc. - Common Stock stock?
Investing in Cogent Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COGT chart and related analysis on metatrader.com as part of your research.